alexa Characterization Of Nano-silica As Diluent In The Tablet Formulation Of A Deliquescent Active Pharmaceutical Ingredient | 35290
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Characterization of nano-silica as diluent in the tablet formulation of a deliquescent active pharmaceutical ingredient

International Conference and Expo on Biopharmaceutics

Musa Autamashih

Kampala International University, Uganda

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X.C1.011

Some Active Pharmaceutical Ingredients (APIs) have been found to be deliquescent in nature and their formulation into solid dosage forms have been difficult and expensive. The conventional approach currently employed in the tablet formulation of deliquescent APIs involves procedures to build a humidity control system in conjunction with a cooling/heating system. Complex instrumentation and digital controls involving expensive gadgets such as a Programmable Logic Controller, a humidity transmitter, a pan humidifier, power contactors, a thermostatically controlled heater and a set of solenoid valves are used. The high cost of total equipment becomes prohibitive for the average users. The innovative approach would be a cheaper procedure involving the use of an efflorescent material as a diluent of the deliquescent API. In this study, a nano-silica namely AEROSIL R927 Pharma® (originally obtained from common sand) was triturated with the deliquescent powdered extract of Vernonia galamensis (the deliquescent API) in the ratio 1:1.4 and carefully formulated into tablets by a ‘closely monitored’ wet granulation procedure. The effect of moisture on the mixture was characterized using FTIR and DSC, and the mechanical strength and quality of tablets were investigated using tensile strength, CSFR:DT ratio, and dissolution rate. Results show that good quality tablets can be produced from deliquescent APIs at an astonishing cheap price and low energy of production.

Musa Autamashih has completed his PhD from Ahmadu Bello University and presented pharmaceutical research innovative papers at the Pharmaceutical Sciences World Congress, Amsterdam, April 25, 2007, and at the American Association of Pharmaceutical Scientists San Diego, California Conference, November 14, 2007. He is currently working on the effect of nano-silica as efflorescent diluent in the solid dosage formulation of deliquescent APIs. He has published 10 papers in reputed journals and is the present Head of Pharmaceutical Research at the School of Pharmacy, Kampala International University in Uganda.

Email: [email protected]